Publications by authors named "Stephen Vernon"

Claim this Profile
E
Evaluating the Role of Lipoprotein(a) in Enhancing Risk Stratification for the Presence and Extent of Subclinical Coronary Artery Disease Burden - A BioHEART-CT Study.
Sina Fathieh, Owen Tang, Michael P Gray, Christian Zanchin, Stephen T Vernon

Eur J Prev Cardiol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of Myeloperoxidase in Patient-Derived Endothelial Colony-Forming Cells-Associations with Coronary Artery Disease and Mitochondrial Function.
Weiqian Eugene Lee, Elijah Genetzakis, Giannie Barsha, Joshua Vescovi, Carmen Mifsud, Stephen T Vernon

Biomolecules· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vascular Cytokines and Atherosclerosis: Differential Serum Levels of TRAIL, IL-18, and OPG in Obstructive Coronary Artery Disease.
Katharine A Bate, Elijah Genetzakis, Joshua Vescovi, Michael P Gray, David S Celermajer, Stephen T Vernon

Biomolecules· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lipidomic Risk Score to Enhance Cardiovascular Risk Stratification for Primary Prevention.
Jingqin Wu, Corey Giles, Aleksandar Dakic, Habtamu B Beyene, Kevin Huynh, Stephen T Vernon

J Am Coll Cardiol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health economic analysis of polygenic risk score use in primary prevention of coronary artery disease - A system dynamics model.
Stephen T Vernon, Stuart Brentnall, Danielle J Currie, Cindy Peng, Michael P Gray

Am J Prev Cardiol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Construction and optimization of multi-platform precision pathways for precision medicine.
Andy Tran, Andy Wang, Jamie Mickaill, Dario Strbenac, Mark Larance, Stephen T Vernon

Sci Rep· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence and Associations of Epiretinal Membranes in an Elderly English Population: The Bridlington Eye Assessment Project.
Craig Wilde, Georgios D Panos, Ali Pooschti, Hamish K MacNab, Jonathan G Hillman, Stephen A Vernon

J Clin Med· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-Throughput Measure of Mitochondrial Superoxide Levels as a Marker of Coronary Artery Disease to Accelerate Drug Translation in Patient-Derived Endothelial Cells Using Opera Phenix Technology.
Weiqian E Lee, Marie Besnier, Elijah Genetzakis, Owen Tang, Katharine A Kott, Stephen T Vernon

Int J Mol Sci· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mass cytometry analysis reveals altered immune profiles in patients with coronary artery disease.
Katharine A Kott, Adam S Chan, Stephen T Vernon, Thomas Hansen, Taiyun Kim

Clin Transl Immunology· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incorporating a polygenic risk score-triaged coronary calcium score into cardiovascular disease examinations to identify subclinical coronary artery disease (ESCALATE): Protocol for a prospective, nonrandomized implementation trial.
Michael P Gray, Yemima Berman, Giordano Bottà, Stuart M Grieve, Amy Ho, Stephen T Vernon

Am Heart J· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Pathway for Coronary Atherosclerosis in Patients Without Conventional Modifiable Risk Factors: JACC State-of-the-Art Review.
Gemma A Figtree, Stephen T Vernon, Jason A Harmer, Michael P Gray, Clare Arnott

J Am Coll Cardiol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum Soluble Lectin-like Oxidized Low-Density Lipoprotein Receptor-1 (sLOX-1) Is Associated with Atherosclerosis Severity in Coronary Artery Disease.
Katharine A Kott, Elijah Genetzakis, Michael P Gray, Peter Hansen, Helen M McGuire, Stephen T Vernon

Biomolecules· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overcoming cohort heterogeneity for the prediction of subclinical cardiovascular disease risk.
Adam S Chan, Songhua Wu, Stephen T Vernon, Owen Tang, Gemma A Figtree

iScience· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lipidomics Profiling and Risk of Coronary Artery Disease in the BioHEART-CT Discovery Cohort.
Dantong Zhu, Stephen T Vernon, Zac D'Agostino, Jingqin Wu, Corey Giles

Biomolecules· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Higher mortality in acute coronary syndrome patients without standard modifiable risk factors: Results from a global meta-analysis of 1,285,722 patients.
Gwyneth Kong, Yip Han Chin, Bryan Chong, Rachel Sze Jen Goh, Oliver Zi Hern Lim, Stephen T Vernon

Int J Cardiol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unexpected Poor Vision within 24 h of Uneventful Phacoemulsification Surgery-A Review.
Harry Rosen, Stephen A Vernon

J Clin Med· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Noninvasive Plaque Imaging to Accelerate Coronary Artery Disease Drug Development.
Gemma A Figtree, Philip D Adamson, Charalambos Antoniades, Roger S Blumenthal, Michael Blaha, Stephen T Vernon

Circulation· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply: The SMuRFs and the SMuRF-Less Gargamel.
Gemma A Figtree, Stephen T Vernon, Stuart M Grieve, Ioanna Kosmidou

JACC Cardiovasc Interv· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of Reduced Vision among UK Elderly Drivers: The Bridlington Eye Assessment Project (BEAP)-A Cross-Sectional Study.
Craig Wilde, Ali Poostchi, Georgios D Panos, Jonathan G Hillman, Hamish K MacNab, Stephen A Vernon

J Ophthalmol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mortality and Cardiovascular Outcomes in Patients Presenting With Non-ST Elevation Myocardial Infarction Despite No Standard Modifiable Risk Factors: Results From the SWEDEHEART Registry.
Gemma A Figtree, Stephen T Vernon, Nermin Hadziosmanovic, Johan Sundström, Joakim Alfredsson

J Am Heart Assoc· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular magnetic resonance characteristics and clinical outcomes of patients with ST-elevation myocardial infarction and no standard modifiable risk factors-A DANAMI-3 substudy.
Jawad Mazhar, Kathrine Ekström, Rebecca Kozor, Stuart M Grieve, Lars Nepper-Christensen, Stephen T Vernon

Front Cardiovasc Med· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The health digital twin to tackle cardiovascular disease-a review of an emerging interdisciplinary field.
Genevieve Coorey, Gemma A Figtree, David F Fletcher, Victoria J Snelson, Stephen Thomas Vernon

NPJ Digit Med· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Outcomes in Patients With ST-Segment Elevation MI and No Standard Modifiable Cardiovascular Risk Factors.
Gemma A Figtree, Bjorn Redfors, Rebecca Kozor, Stephen T Vernon, Stuart M Grieve

JACC Cardiovasc Interv· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrating a Polygenic Risk Score for Coronary Artery Disease as a Risk-Enhancing Factor in the Pooled Cohort Equation: A Cost-Effectiveness Analysis Study.
Deo Mujwara, Geoffrey Henno, Stephen T Vernon, Siyang Peng, Paolo Di Domenico

J Am Heart Assoc· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biomarker Development in Cardiology: Reviewing the Past to Inform the Future.
Katharine A Kott, Michael Bishop, Christina H J Yang, Toby M Plasto, Daniel C Cheng, Stephen T Vernon

Cells· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis